메뉴 건너뛰기




Volumn 105, Issue 20, 2013, Pages 1521-1522

Ductal carcinoma in situ: A rose by any other name

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

EID: 84886067418     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djt268     Document Type: Editorial
Times cited : (13)

References (18)
  • 1
    • 78650717087 scopus 로고    scopus 로고
    • Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast
    • Early Breast Cancer Trialists' Collaborative Group
    • Early Breast Cancer Trialists' Collaborative Group. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr. 2010;2010(41):162-177.
    • (2010) J Natl Cancer Inst Monogr. , vol.2010 , Issue.41 , pp. 162-177
  • 2
    • 1642345591 scopus 로고    scopus 로고
    • Trends in the treatment of ductal carcinoma in situ of the breast
    • Baxter NN, Virnig BA, Durham SB, Tuttle TM. Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst. 2004;96(6):443-448.
    • (2004) J Natl Cancer Inst. , vol.96 , Issue.6 , pp. 443-448
    • Baxter, N.N.1    Virnig, B.A.2    Durham, S.B.3    Tuttle, T.M.4
  • 3
    • 0003964363 scopus 로고    scopus 로고
    • American Cancer Society. Atlanta: American Cancer Society. Accessed August 12, 2013
    • American Cancer Society. Cancer Facts & Figures. Atlanta: American Cancer Society; 2008. http://www.cancer.org/research/cancerfactsstatistics/ cancerfactsfigures2008/index. Accessed August 12, 2013.
    • (2008) Cancer Facts & Figures
  • 4
    • 84886049860 scopus 로고    scopus 로고
    • Treatment of ductal carcinoma in situ after excition: Would a prophylactic paradigm be more appropriate?
    • Punglia R, Schnitt S, and Weeks, J. Treatment of ductal carcinoma in situ after excition: would a prophylactic paradigm be more appropriate? J Natl Cancer Inst. 2013;105(20): 1527-1533.
    • (2013) J Natl Cancer Inst. , vol.105 , Issue.20 , pp. 1527-1533
    • Punglia, R.1    Schnitt, S.2    Weeks, J.3
  • 6
    • 0035860140 scopus 로고    scopus 로고
    • Tumour markers in breast carcinoma correlate with grade rather than with invasiveness
    • Wärnberg F, Nordgren H, Bergkvist L, Holmberg L. Tumour markers in breast carcinoma correlate with grade rather than with invasiveness. Br J Cancer. 2010;85(6):869-874.
    • (2010) Br J Cancer. , vol.85 , Issue.6 , pp. 869-874
    • Wärnberg, F.1    Nordgren, H.2    Bergkvist, L.3    Holmberg, L.4
  • 7
    • 0037361170 scopus 로고    scopus 로고
    • Molecular markers in ductal carcinoma in situ of the breast
    • Porter D, Lahti-Domenici J, Keshaviah A, et al. Molecular markers in ductal carcinoma in situ of the breast. Mol Cancer Res. 2003;1(5): 362-375.
    • (2003) Mol Cancer Res. , vol.1 , Issue.5 , pp. 362-375
    • Porter, D.1    Lahti-Domenici, J.2    Keshaviah, A.3
  • 8
    • 0038137601 scopus 로고    scopus 로고
    • Gene expression profiles of human breast cancer progression
    • Ma XJ, Salunga R, Tuggle JT, et al. Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci U S A. 2003;100(10):5974-5979.
    • (2003) Proc Natl Acad Sci U S A. , vol.100 , Issue.10 , pp. 5974-5979
    • Ma, X.J.1    Salunga, R.2    Tuggle, J.T.3
  • 9
    • 67549115421 scopus 로고    scopus 로고
    • The transition from ductal carcinoma in situ to invasive breast cancer: The other side of the coin
    • Schnitt SJ. The transition from ductal carcinoma in situ to invasive breast cancer: the other side of the coin. Breast Cancer Res. 2009;11(1):101.
    • (2009) Breast Cancer Res. , vol.11 , Issue.1 , pp. 101
    • Schnitt, S.J.1
  • 10
    • 33747095513 scopus 로고    scopus 로고
    • Do myoephithelial cells hold the key for breast tumor progression?
    • Polyak K, Hu M. Do myoephithelial cells hold the key for breast tumor progression? J Mammary Gland Biol Neoplasia. 2005;10(3):231-247.
    • (2005) J Mammary Gland Biol Neoplasia. , vol.10 , Issue.3 , pp. 231-247
    • Polyak, K.1    Hu, M.2
  • 11
    • 79952845819 scopus 로고    scopus 로고
    • Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS
    • Wapnir IL, Dignam JJ, Fisher B, et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst. 2011;103:478-488.
    • (2011) J Natl Cancer Inst. , vol.103 , pp. 478-488
    • Wapnir, I.L.1    Dignam, J.J.2    Fisher, B.3
  • 12
    • 0033549344 scopus 로고    scopus 로고
    • Tamoxifen in treatment of intraductal breast cancer: National surgical adjuvant breast and bowel project B-24 randomised controlled trial
    • Fisher B, Dignam J, Wolmark N, et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet. 1999;353:1993-2000.
    • (1999) Lancet. , vol.353 , pp. 1993-2000
    • Fisher, B.1    Dignam, J.2    Wolmark, N.3
  • 13
    • 79959403574 scopus 로고    scopus 로고
    • Exemestane for breast cancer prevention in postmenopausal women
    • Goss PE, Ingle JN, Alés-Martínez JE, et al. Exemestane for breast cancer prevention in postmenopausal women. N Engl J Med. 2011; 364(25):2381-2391.
    • (2011) N Engl J Med. , vol.364 , Issue.25 , pp. 2381-2391
    • Goss, P.E.1    Ingle, J.N.2    Alés-Martínez, J.E.3
  • 14
    • 84874745627 scopus 로고    scopus 로고
    • Long term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years afte diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomized trial
    • Davies C, Pan H, Godwin J, et al. Long term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years afte diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomized trial. Lancet. 2013;381(9869):805-816.
    • (2013) Lancet. , vol.381 , Issue.9869 , pp. 805-816
    • Davies, C.1    Pan, H.2    Godwin, J.3
  • 15
    • 84878978550 scopus 로고    scopus 로고
    • ATTom: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer
    • abstract 5
    • Gray RG, Rea D, Handley K, et al. aTTom: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer. J Clin Oncol. 2013;31(Suppl):abstract 5.
    • (2013) J Clin Oncol. , vol.31 , Issue.SUPPL.
    • Gray, R.G.1    Rea, D.2    Handley, K.3
  • 16
    • 33644972703 scopus 로고    scopus 로고
    • Prospective study of wide excision alone for ductal carcinoma in situ of the breast
    • Wong JS, Kaelin CM, Troyan SL, et al. Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol. 2006;24(7):1031-1036.
    • (2006) J Clin Oncol. , vol.24 , Issue.7 , pp. 1031-1036
    • Wong, J.S.1    Kaelin, C.M.2    Troyan, S.L.3
  • 17
    • 73949085809 scopus 로고    scopus 로고
    • Local excision alone without irradiation for ductal carcinoma in situ of the breast: A trial of the eastern cooperative oncology group
    • Hughes LL, Wang M, Page DL, et al. Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol. 2009;27(32):5319-5324.
    • (2009) J Clin Oncol. , vol.27 , Issue.32 , pp. 5319-5324
    • Hughes, L.L.1    Wang, M.2    Page, D.L.3
  • 18
    • 84877950429 scopus 로고    scopus 로고
    • A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast
    • Solin LJ, Gray R, Baehner FL, et al. A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast. J Natl Cancer Inst. 2013;105(10):701-710.
    • (2013) J Natl Cancer Inst. , vol.105 , Issue.10 , pp. 701-710
    • Solin, L.J.1    Gray, R.2    Baehner, F.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.